STX-001

N/A

Report date: 2024/11/20 17:52:22

Base Information

Drug NameSTX-001
Drug Alias NameSTX-001
ClassificationCell and gene therapy > Gene therapy > mRNACell and gene therapy > Gene therapy > LNP
Mechanisms of ActionInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsSolid tumoursTriple Negative Breast NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesStrand Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursTriple Negative Breast NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A